← TREACE MEDICAL CONCEPTS, INC.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.4m |
$57.4m
+45.54%
|
$94.4m
+64.59%
|
$141.8m
+50.22%
|
$187.1m
+31.92%
|
$209.4m
+11.89%
|
$212.7m
+1.59%
|
$205.3m
-3.47%
|
|
| Cost of goods sold | $7.6m |
$12.5m
+63.41%
|
$17.8m
+42.95%
|
$27.5m
+54.40%
|
$35.2m
+27.82%
|
$41.1m
+16.80%
|
$42.9m
+4.49%
|
$42.2m
-1.75%
|
|
| Gross profit | $31.8m |
$44.9m
+41.25%
|
$76.6m
+70.60%
|
$114.3m
+49.25%
|
$151.9m
+32.91%
|
$168.3m
+10.75%
|
$169.8m
+0.88%
|
$163.1m
-3.91%
|
|
| Research and development | $5.1m | $5.8m | $10.2m | $13.6m | $15.4m | $20.6m | $20.3m | $18.2m | |
| Sales and marketing | $25.8m | $31.7m | $64.5m | $102.6m | $140.9m | $147.6m | $140.9m | — | |
| General and administrative | $4.5m | $6.5m | $18.4m | $33.0m | $47.0m | $55.7m | $62.7m | $62.2m | |
| Total operating expenses | $35.3m | $44.0m | $93.1m | $149.2m | $203.4m | $224.0m | $223.9m | $216.8m | |
| Loss from operations | ($3.5m) |
$855k
+124.19%
|
($16.5m)
-2030.99%
|
($34.8m)
-111.05%
|
($51.4m)
-47.59%
|
($55.7m)
-8.28%
|
($54.2m)
+2.75%
|
— | |
| Interest expense | ($841k) | ($2.8m) | ($4.1m) | ($4.4m) | ($5.2m) | ($5.3m) | ($5.3m) | $5.8m | |
| Interest income | $111k | ($1.7m) | $18k | $910k | $6.7m | $4.9m | $2.8m | $2.1m | |
| Unrealized gain (loss) on marketable securities | — | $0 | $0 | ($27k) | $190k | ($66k) | ($25k) | — | |
| Other income, net | — | — | $1k | ($403k) | $342k | $324k | $432k | ($2.1m) | |
| Other non-operating income (expense), net | ($730k) | ($4.5m) | ($4.0m) | ($8.0m) | $1.9m | ($55k) | ($4.8m) | — | |
| Net loss | ($4.3m) | ($3.7m) | ($20.6m) | ($42.8m) | ($49.5m) | ($55.7m) | ($59.0m) | — | |
| Net loss per share, basic | — | ($0) | ($0) | ($1) | ($1) | ($1) | ($1) | — | |
| Net loss per share, diluted | — | ($0) | ($0) | ($1) | ($1) | ($1) | ($1) | — | |
| Weighted-average shares used in computing net loss per share, basic | — | ($0) | ($0) | ($1) | ($1) | ($1) | ($1) | — | |
| Weighted-average shares used in computing net loss per share, diluted | — | ($0) | ($0) | ($1) | ($1) | ($1) | ($1) | — | |
| Debt extinguishment loss | — | $0 | $0 | ($4.5m) | $0 | $0 | ($2.7m) | — | |
| Comprehensive loss | — | ($4.3m) | ($20.7m) | ($42.8m) | ($49.3m) | ($55.8m) | ($59.0m) | — |